GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, AKR1C3, APP, BCL2, CDC25B, CHRM1, CSNK2A1, CYP1B1, DNMT1, DRD2, DRD3, EGFR, ESR1, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, NUAK1, PIM1, SMAD3, SRC, TEK, TERT, XDH |
11.6347 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AKR1C3, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, INSR, KDR, KIT, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
11.6347 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AKR1C3, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, INSR, KDR, KIT, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
11.6347 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD11B1, HSD17B1, HSPA1A, INSR, KDR, KIT, MET, PPARA, SMAD3, SRC, TEK, TERT, XDH |
11.6347 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
10.9618 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AKR1C3, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
10.9598 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, F3, FABP3, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
10.9598 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AKR1C3, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
10.8448 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, PPARA, RORC, SMAD3, SRC, TEK |
10.7843 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, PPARA, RORC, SMAD3, SRC, TEK, TERT |
10.5973 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, IGF1R, INSR, MMP2, MMP9, PPARA, RORC, SRC, TEK |
10.4793 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, DYRK1A, EGFR, ESR1, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
10.294 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, AKR1C3, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, DRD1, DRD5, EGFR, ESR1, FABP3, FLT3, IGF1R, INSR, KIT, MMP2, PPARA, SMAD3, SRC, TEK |
10.294 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CHRM1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT |
10.2626 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT |
9.50333 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, KIT, MMP9, SRC, TERT |
9.17304 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, DRD2, DRD3, EGFR, F10, F3, INSR, KIT, MET, SRC, TEK, XDH |
9.15078 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, RORC, SMAD3, SRC, TERT |
9.15078 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FLT3, RORC, SRC, TEK |
9.09095 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT |
9.08468 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AKR1C3, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, KIT, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
9.02204 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, DRD1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
8.95415 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AKR1C3, APP, AXL, BCL2, CYP1B1, DRD2, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, KIT, MET, PTPN1, SRC, TEK, XDH |
8.66844 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, EGFR, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, KIT, MET, PPARA |
8.63772 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, APP, AXL, BCL2, CA2, CA7, CHRM1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, TERT |
8.58872 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AKR1C3, BCL2, CDC25B, CHRM1, CSNK2A1, DRD2, DRD3, EGFR, ESR1, F3, FLT3, IGF1R, INSR, KDR, KIT, MMP2, MMP9, PIM1, TEK, TERT |
8.58872 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT |
8.55375 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT |
8.53122 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, PIM1, SRC, TEK |
8.40908 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT |
8.36374 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HSPA1A, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
8.36374 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HSPA1A, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
8.28546 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT |
8.20974 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
8.18985 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, APP, AXL, BCL2, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F10, F3, FABP4, IGF1R, INSR, KIT, MET, MMP1, MMP2, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK |
8.18844 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT |
8.03076 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, DRD1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
7.90817 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA3, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KIT, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
7.89802 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MMP2, RORC, SMAD3, SRC |
7.88821 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
7.49718 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
7.47049 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
7.43875 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, HSD11B1, HSD17B1 |
7.41953 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AKR1C3, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, NUAK1, PTPN1, RORC, SMAD3, SRC, TERT |
7.33233 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, TERT |
7.31871 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, AKR1C3, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F10, F3, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, KIT, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
7.21955 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, FABP4, FLT3, FUT7, HSD11B1, INSR, KDR, KIT, MET, MMP2, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK, TERT |
7.19936 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, AKR1C3, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, INSR, KIT, PPARA, SRC, TEK |
7.19383 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, BCL2, CDC25B, CHRM5, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
7.19383 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CA2, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, FLT3, HSD11B1, INSR, KDR, KIT, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK |
7.15037 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AKR1C3, AXL, EGFR, F10, F3, INSR, KIT, MET, SRC, TEK |
7.15037 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, TERT |
7.15037 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, BCL2, CDC25B, CHRM5, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
7.14518 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.12606 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, MET, SMAD3, SRC, TERT |
7.05595 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
6.99356 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HSPA1A, IGF1R, KDR, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
6.99356 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, NUAK1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT |
6.86594 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, DYRK1A, EGFR, ESR1, KIT, PPARA, RORC, SRC |
6.85112 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, DRD1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, TERT, XDH |
6.77018 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KIT, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
6.76664 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, DRD1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, TERT, XDH |
6.75619 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, AKR1C3, CHRM5, CYP1A1, DRD3, FABP3, FLT3, HCAR2, KIT, PPARA, RORC, SRC, TEK |
6.7479 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
6.69387 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DNMT1, DRD1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
6.68066 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.65391 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, KIT |
6.61837 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, KIT |
6.61837 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AXL, BCL2, CA1, CA2, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP1B1, DNMT1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK |
6.58593 |
[BP] GO:0007200 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD5, ESR1 |
6.58385 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, AKR1C3, APP, AURKB, BCL2, CDC25B, DNMT1, DRD1, DRD2, DRD3, DRD5, DYRK1A, EGFR, ESR1, ESR2, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
6.56486 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, APP, CYP19A1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, MET, MMP2, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
6.55467 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, BCL2, CHRM1, CHRM3, CHRM5, CYP1A1, EGFR, ESR1, FLT3, KIT, MET, PIM1, SRC, TEK |
6.46275 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, KIT, MMP9, TERT |
6.37197 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, AKR1C3, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DRD3, DRD5, DYRK1A, EGFR, ESR1, ESR2, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
6.36535 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DRD3, DRD5, DYRK1A, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
6.34552 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, DRD3, EGFR, HSPA1A, KIT, MMP2, PPARA, SMAD3, SRC, TEK, TERT |
6.2776 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PTPN1, SRC, TEK, XDH |
6.25839 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.25096 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.1032 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DRD1, DRD2, DRD3, DUSP3, DYRK1A, EGFR, ESR1, F10, F3, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
6.06525 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, DRD5, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
6.02567 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DNMT1, DRD1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, FABP3, FABP4, GPR35, HCAR2, HSPA1A, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
5.99602 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, ALPL, APP, CYP1A1, CYP1B1, DRD1, DRD5, EGFR, ESR1, FLT3, RORC, SRC |
5.95828 |
[BP] GO:0007188 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 |
5.93265 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, FLT3, HSD11B1, INSR, KDR, KIT, PPARA, SMAD3, SRC, TEK |
5.92126 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3 |
5.91012 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, APP, AURKB, BCL2, CDC25B, DRD2, DRD5, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, INSR, KIT, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
5.90154 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PTPN1, SRC, TEK, XDH |
5.89621 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, APP, AXL, BCL2, CA2, CHRM1, CYP19A1, DRD1, DRD2, DRD3, EGFR, HCAR2, INSR, SMAD3, SRC, TERT |
5.79173 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, BCL2, CYP19A1, DRD1, DRD2, DRD3, DUSP3, DYRK1A, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
5.76238 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, TERT |
5.74798 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, BCL2, CDC25B, DRD1, DRD2, DRD5, EGFR, FABP3, FLT3, INSR, KDR, KIT, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
5.69455 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, BCL2, CDC25B, DRD1, DRD2, DRD5, EGFR, FABP3, FLT3, INSR, KDR, KIT, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
5.69455 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, APP, AXL, CYP1B1, DNMT1, DRD1, DRD5, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, RORC, SRC |
5.69298 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3 |
5.65964 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK |
5.64834 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DRD2, DRD5, EGFR, PPARA, SMAD3 |
5.47592 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, APP, AXL, BCL2, CA2, CA7, CHRM1, CYP19A1, DRD1, DRD2, DRD3, EGFR, GPR35, HCAR2, HSPA1A, INSR, MMP9, PPARA, PTPN1, SMAD3, SRC, TERT |
5.42828 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, AKR1C3, APP, DNMT1, DRD1, DRD5, EGFR, ESR1, FLT3, IGF1R, INSR, KIT, MMP2, SMAD3, SRC |
5.4267 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
5.41843 |
[BP] GO:0007187 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 |
5.41005 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, KDR, SRC |
5.39411 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
5.38318 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DRD3, DYRK1A, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
5.3826 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B1 |
5.3826 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, BCL2, DNMT1, DRD2, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, SMAD3, SRC, TEK |
5.32527 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, PTPN1, SRC, TEK |
5.32449 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, DRD1, DRD2, DRD3, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
5.31813 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK, TERT |
5.24688 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK |
5.24688 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
5.24688 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, ESR1, HCAR2, HSD11B1, HSD17B1 |
5.24688 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AKR1C3, APP, AURKB, BCL2, CSNK2A1, CYP2D6, DNMT1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, FABP4, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TERT, XDH |
5.24688 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, DRD1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD11B1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
5.19664 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DRD2, DYRK1A, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, KDR, KIT, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
5.19664 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, APP, BCL2, CDC25B, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
5.19431 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DRD3, DUSP3, DYRK1A, ESR1, HSPA1A, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
5.18448 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, RORC, SRC |
5.18448 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK, TERT |
5.15407 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, EGFR, FABP3, FABP4, FUT7, KIT, MET, PPARA |
5.09669 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, EGFR, KIT, MMP9, TERT |
5.09006 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, HSPA1A |
5.09006 |
[BP] GO:0050890 |
None
|
ADORA1, APP, CHRM1, DRD1, DRD2, DRD3, DRD5, EGFR, INSR, KIT |
5.09006 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, KDR, SRC |
5.08493 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, DRD3, KDR, SRC |
5.0142 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, DNMT1, DRD2, DYRK1A, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, KDR, KIT, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
4.94967 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, BCL2, CA2, CHRM3, CYP1B1, DRD2, DRD3, EGFR, F3, HCAR2, HSPA1A, KDR, KIT, MET, MMP9, PIM1, SMAD3, SRC, TEK, TERT |
4.94077 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, EGFR, F10, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
4.90006 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AXL, BCL2, CA2, CHRM1, CHRM2, CHRM3, CYP1B1, DRD2, DRD3, EGFR, ESR1, F3, GPR35, HCAR2, HSPA1A, INSR, KDR, KIT, MET, MMP9, PIM1, SMAD3, SRC, TEK, TERT, XDH |
4.89863 |
[BP] GO:0003018 |
None
|
ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, SRC, TEK |
4.87132 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, SRC, TERT |
4.85717 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK, TERT |
4.84911 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, AKR1C3, APP, AURKB, BCL2, CA9, CDC25B, CHRM5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, DRD1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
4.81787 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FUT7, HSPA1A, PIM1, PPARA, XDH |
4.81553 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, APP, AURKB, BCL2, CDC25B, DRD2, DRD5, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, KIT, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
4.81384 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, GPR35, SMAD3 |
4.79646 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR |
4.77452 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
4.76463 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1 |
4.75684 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, CYP1B1, EGFR, MMP9, SRC |
4.75684 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HCAR2, KDR, SRC |
4.7374 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.62665 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.56151 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, KIT |
4.53737 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
4.52834 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
CHRM5, FABP3, FLT3, KIT, SRC, TEK |
4.50572 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, AKR1C3, APP, AURKB, BCL2, CA9, CDC25B, CHRM5, CSNK2A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
4.4653 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, DRD2, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, KIT, PTPN1, SRC, TEK, XDH |
4.45813 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MMP9, PPARA, PTPN1, SRC, TEK, XDH |
4.45709 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.45709 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1, DRD2, EGFR |
4.44739 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CHRM1, CHRM3, CSNK2A1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, F10, F3, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK |
4.44586 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3 |
4.44261 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, DRD2, EGFR, FLT3, INSR, KDR, KIT, PTPN1, SRC, TEK, XDH |
4.43401 |
[BP] GO:0050789 |
regulation of biological process
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, DRD1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
4.43401 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, AKR1C3, CSNK2A1, DRD1, DRD2, DRD3 |
4.40972 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MMP9, PTPN1, SRC, TEK, XDH |
4.37778 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, DRD2, DRD3, EGFR, GPR35, HCAR2, KIT, SMAD3 |
4.3717 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR |
4.3717 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
4.35825 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CHRM1, CHRM3, CSNK2A1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK |
4.35656 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DNMT1, DRD1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
4.32418 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, DRD5, PPARA |
4.31251 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AKR1C3, APP, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
4.28111 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, CYP2D6, MET, MMP9, PPARA, SMAD3, SRC, TERT |
4.28111 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC, TEK |
4.2687 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, SMAD3 |
4.24132 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
4.22951 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, AKR1C3, APP, AURKB, BCL2, CA9, CDC25B, CHRM5, CSNK2A1, CYP1B1, CYP2D6, DNMT1, DRD1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
4.18895 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
4.17984 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, AKR1C3, APP, CA2, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, HCAR2, INSR, SRC |
4.16413 |
[BP] GO:0007612 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, INSR, KIT |
4.15954 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, BCL2, CDC25B, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TERT |
4.13242 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD5, EGFR, HSPA1A, KIT, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TERT |
4.12992 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.09824 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, EGFR, ESR1, F3, FABP4, KDR, MET, PPARA, SMAD3, TEK |
4.07703 |
[BP] GO:0003013 |
None
|
ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, SRC, TEK |
4.07703 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
4.07703 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, DRD3, KIT |
4.05968 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APP, CDC25B, CYP1A1, DRD3, DUSP3, INSR, TERT |
4.01409 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DRD2, DRD3, DUSP3, DYRK1A, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, TERT, XDH |
4.00857 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, BCL2, CDC25B, DNMT1, DRD2, DYRK1A, EGFR, FLT3, INSR, KDR, KIT, MMP9, PTPN1, SRC, TEK, XDH |
3.89077 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, DRD1, DRD5, EGFR, ESR1, INSR, KIT, MMP2, MMP9, SRC |
3.87364 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.87153 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.87153 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, BCL2, CDC25B, DRD2, EGFR, FLT3, INSR, KDR, KIT, MMP9, PTPN1, SRC, TEK, XDH |
3.86091 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, DRD3, KIT |
3.86091 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
3.84676 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
3.84057 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AKR1C3, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP2, MMP9, SRC, XDH |
3.82861 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
3.82744 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, DNMT1, DRD1, DRD2, DRD3, DRD5, EGFR, IGF1R, INSR, KDR, KIT, MET, NUAK1, PTPN1, SRC, TEK |
3.7965 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, DRD5, EGFR, IGF1R, INSR, MMP2, SRC |
3.79561 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HCAR2 |
3.79339 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.77413 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, AKR1C3, APP, BCL2, CHRM1, CHRM3, CHRM5, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, INSR, KIT, SRC, TEK |
3.764 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DUSP3, DYRK1A, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
3.74458 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, APP, BCL2, CA2, CA7, CHRM1, DRD1, DRD2, DRD3, GPR35, MMP9 |
3.74444 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, DRD5, EGFR |
3.74444 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, APP, AURKB, AXL, BCL2, CDC25B, CHRM1, CHRM3, CSNK2A1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK |
3.74444 |
[BP] GO:0036211 |
protein modification process
|
ALPL, APP, AURKB, AXL, BCL2, CDC25B, CHRM1, CHRM3, CSNK2A1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK |
3.74444 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KIT, PTPN1, SRC, TEK |
3.72156 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
3.70186 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
AURKB, BCL2, DNMT1, DRD3, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.70185 |
[BP] GO:0007611 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, EGFR, INSR, KIT |
3.6919 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3, DRD5 |
3.69116 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AURKB, DNMT1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, MET, PPARA, PTPN1, RORC, SMAD3, SRC, TERT |
3.67593 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, BCL2, CDC25B, DRD2, EGFR, FLT3, INSR, KDR, KIT, MMP9, PTPN1, SRC, TEK, XDH |
3.66733 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.65537 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.65537 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.65537 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.65537 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.65537 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.6363 |
[BP] GO:0055080 |
cation homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, SMAD3 |
3.62942 |
[BP] GO:0008406 |
gonad development
|
AKR1C3, BCL2, CYP19A1, ESR1, INSR, KIT |
3.62942 |
[BP] GO:0007154 |
None
|
ADORA1, AKR1C3, AXL, BCL2, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, ESR2, TEK |
3.62942 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, BCL2, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, SMAD3 |
3.6262 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
AKR1C3, BCL2, CYP1B1, EGFR, INSR, SMAD3, XDH |
3.6262 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD11B1, HSD17B1 |
3.61733 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KIT, PTPN1, SRC, TEK |
3.55116 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, DRD5, EGFR, IGF1R, INSR, MMP2, SRC |
3.54007 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AKR1C3, ALPL, APP, AXL, BCL2, CDC25B, CYP1A1, DRD1, DRD2, EGFR, ESR1, FABP4, FLT3, FUT7, KDR, KIT, MET, MMP2, MMP9, RORC, SMAD3, SRC, TEK, TERT |
3.51977 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, DRD5 |
3.51977 |
[BP] GO:0001503 |
ossification
|
ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
3.50624 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.5017 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, SRC, TERT |
3.49505 |
[BP] GO:0006940 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, KIT |
3.49263 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, KIT, PTPN1, SRC |
3.48204 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
AKR1C3, APP, AURKB, BCL2, CSNK2A1, CYP2D6, DNMT1, DRD2, DRD3, DUSP3, DYRK1A, ESR1, ESR2, FABP4, HSPA1A, IGF1R, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TERT, XDH |
3.47696 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
3.47543 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, EGFR, INSR, SMAD3 |
3.47518 |
[BP] GO:0043412 |
macromolecule modification
|
ALPL, APP, AURKB, AXL, BCL2, CDC25B, CHRM1, CHRM3, CSNK2A1, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK |
3.44351 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
AKR1C3, CYP1A2, EGFR, MMP9 |
3.4213 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, MMP2, PPARA, PTPN1, SMAD3, SRC, TEK |
3.39952 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, DRD1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, FUT7, GPR35, HCAR2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
3.39066 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KIT, PTPN1, SRC |
3.39066 |
[BP] GO:0051128 |
regulation of cellular component organization
|
APP, AURKB, AXL, BCL2, CSNK2A1, DNMT1, DRD2, DRD3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, PTPN1, SMAD3, SRC, TEK |
3.38734 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, DRD1, DRD2, DRD3, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, F3, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
3.38734 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.37876 |
[BP] GO:0007191 |
None
|
DRD1, DRD3, DRD5 |
3.37876 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.37876 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.37876 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, SRC, TEK |
3.34909 |
[BP] GO:0097746 |
None
|
ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR |
3.33219 |
[BP] GO:0035296 |
None
|
ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR |
3.33219 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
3.33219 |
[BP] GO:0048608 |
reproductive structure development
|
AKR1C3, AXL, BCL2, CYP19A1, ESR1, INSR, KIT, SRC |
3.32146 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
3.32146 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
3.32013 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, INSR, TERT |
3.28055 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
APP, DRD2, DUSP3, EGFR, KDR, PTPN1, SRC, TEK |
3.28055 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.25909 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR |
3.24054 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
3.23036 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, PPARA, SMAD3, TEK |
3.23036 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, TERT |
3.20741 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.19934 |
[BP] GO:0050880 |
None
|
ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR |
3.19712 |
[BP] GO:0035150 |
None
|
ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR |
3.17973 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD1, DRD2, DRD3, EGFR, KIT |
3.1701 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, DRD3 |
3.15895 |
[BP] GO:0007212 |
None
|
DRD1, DRD2, DRD3, DRD5 |
3.15612 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
3.15612 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, BCL2, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
3.14415 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, APP, AURKB, BCL2, CA9, CDC25B, CHRM5, CSNK2A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DRD3, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
3.13887 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, DYRK1A, EGFR, PPARA, RORC |
3.13528 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, EGFR, HSPA1A, INSR, TERT |
3.11991 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AKR1C3, ALPL, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, INSR, KIT, SRC |
3.11991 |
[BP] GO:0014075 |
None
|
DRD1, DRD2, DRD3, DRD5 |
3.11991 |
[BP] GO:0007268 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 |
3.11266 |
[BP] GO:0098916 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 |
3.11266 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, PPARA |
3.07385 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, DRD2, DRD3, GPR35, MMP9 |
3.06991 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
3.06991 |
[BP] GO:0060158 |
None
|
DRD1, DRD2, DRD5 |
3.06991 |
[BP] GO:0046960 |
None
|
DRD1, DRD5 |
3.06991 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
3.06991 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
3.06991 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
3.06991 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
3.06991 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, BCL2, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
3.06991 |
[BP] GO:0099536 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 |
3.06029 |
[BP] GO:0099537 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 |
3.06029 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, BCL2, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
3.03011 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DNMT1, DRD1, DRD2, DRD3, DRD5, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
3.02027 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, CHRM1, CHRM3, DRD2, F10, F3, MET, XDH |
3.01536 |
[BP] GO:0048545 |
response to steroid hormone
|
AKR1C3, ALPL, BCL2, CA2, EGFR, FLT3, SRC |
3.0058 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.97935 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.97935 |
[BP] GO:0007267 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, ESR2, TEK |
2.97935 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.96749 |
[BP] GO:0008217 |
None
|
ADORA1, DRD2, DRD3, DRD5, PPARA, SMAD3 |
2.95336 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.94539 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.94539 |
[BP] GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
2.94539 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, FABP3, IGF1R, INSR, KDR, MET, PPARA, RORC, SMAD3, SRC, TERT |
2.9171 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
AKR1C3, EGFR, INSR, SMAD3, XDH |
2.91608 |
[BP] GO:0022898 |
None
|
ABCB1, APP, BCL2, DRD2, DRD3, GPR35, MMP9 |
2.91141 |
[BP] GO:0048167 |
None
|
ADORA1, APP, DRD1, DRD2, DRD5, KIT |
2.88429 |
[BP] GO:0050730 |
None
|
ADORA1, APP, EGFR, FLT3, KIT, PTPN1, SRC |
2.87732 |
[BP] GO:0097366 |
None
|
DRD1, DRD2, DRD3, DRD5 |
2.87692 |
[BP] GO:0008584 |
None
|
AKR1C3, BCL2, ESR1, INSR, KIT |
2.87692 |
[BP] GO:0031960 |
response to corticosteroid
|
AKR1C3, ALPL, BCL2, EGFR, FLT3, SRC |
2.87669 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.87669 |
[BP] GO:0046903 |
None
|
ALOX5, APP, AXL, CA2, CA9, CHRM1, CHRM3, CHRM5, DRD2, DRD3, HSPA1A, KIT, MMP9, XDH |
2.87458 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, AKR1C3, DNMT1, EGFR, FABP3, KDR, MMP2, SRC |
2.86418 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, DYRK1A, EGFR, HSPA1A, IGF1R, MET, NUAK1, PTPN1, TERT, XDH |
2.86246 |
[BP] GO:0040008 |
regulation of growth
|
APP, BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR2, HSPA1A, INSR, PIM1, SMAD3 |
2.84029 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
2.84029 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.82989 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, TERT |
2.82989 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.82989 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTPN1, SRC |
2.8257 |
[BP] GO:0007610 |
None
|
APP, BCL2, DRD1, DRD2, DRD3, DRD5, EGFR, INSR, KIT, PPARA |
2.81503 |
[BP] GO:0003014 |
None
|
ADORA1, AKR1B1, AKR1C3, BCL2, DRD2 |
2.80712 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, KDR, KIT, TEK |
2.78876 |
[BP] GO:0016101 |
None
|
AKR1B10, AKR1C3, CYP1A1, CYP1B1, EGFR |
2.78876 |
[BP] GO:0055065 |
metal ion homeostasis
|
APP, BCL2, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, SMAD3 |
2.78776 |
[BP] GO:0032409 |
None
|
ABCB1, APP, BCL2, DRD2, DRD3, GPR35, MMP9 |
2.77678 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, PPARA, RORC |
2.77198 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, FLT3, INSR, KIT, PTPN1, SRC, TEK |
2.77198 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AXL, CYP1A1, DRD1, DRD5, EGFR, ESR1, KIT, SRC |
2.7637 |
[BP] GO:2000351 |
None
|
AKR1C3, KDR, TEK, TERT |
2.7637 |
[BP] GO:0034762 |
None
|
ABCB1, APP, BCL2, CA2, DRD1, DRD2, DRD3, GPR35, MMP9 |
2.75723 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.73932 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.72284 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.72284 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.72284 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.72284 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.69749 |
[BP] GO:0019226 |
None
|
CHRM5, DRD1, DRD5 |
2.69749 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, CHRM1, DRD2, DRD3, EGFR, HCAR2, PTPN1, SMAD3, SRC |
2.69631 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, DRD2, EGFR, FLT3, INSR, KIT, PTPN1, SRC, TEK |
2.68722 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, SMAD3, SRC, TEK |
2.68722 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, PPARA, SMAD3, TEK |
2.68022 |
[BP] GO:0043550 |
regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
2.67841 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.67841 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.67841 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.67841 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, F3, INSR, KDR, KIT, PIM1, SMAD3, SRC, TEK, TERT, XDH |
2.67763 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
AKR1C3, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.67342 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, F3, INSR, KDR, KIT, NUAK1, PIM1, PPARA, RORC, SMAD3, SRC, TEK, TERT, XDH |
2.66832 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, IGF1R, INSR, PPARA, SRC, TEK |
2.66622 |
[BP] GO:0001775 |
cell activation
|
ALOX5, APP, AXL, BCL2, EGFR, FLT3, FUT7, HSPA1A, KIT, MMP9, RORC, SMAD3, SRC |
2.65853 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.64186 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.64186 |
[BP] GO:0007617 |
None
|
APP, DRD1, DRD5 |
2.64186 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, KDR, KIT, TEK, TERT |
2.63973 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, PIM1, PPARA, RORC, SRC |
2.63973 |
[BP] GO:0023052 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, ESR2, TEK |
2.63104 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AXL, BCL2, CA2, CYP1B1, DRD2, F3, INSR, KDR, KIT, PIM1, SMAD3, SRC, TEK, TERT |
2.6304 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.62952 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.62952 |
[BP] GO:0048729 |
tissue morphogenesis
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.62667 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, KIT, MMP9, RORC |
2.61528 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.61528 |
[BP] GO:0048731 |
system development
|
ACHE, ADORA1, ALPL, CHRM1, CHRM2, CHRM3, DYRK1A, MMP9, SMAD3, SRC, TEK |
2.61414 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, BCL2, CYP1B1, DRD2, FABP3, HSPA1A, SMAD3, TERT, XDH |
2.61414 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, KIT, MMP1, MMP9, SRC, TEK |
2.61094 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.60895 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, EGFR, HCAR2, MET, PPARA, SMAD3 |
2.6007 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3 |
2.59519 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.59519 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, FLT3, INSR, KIT, PTPN1, SRC |
2.59519 |
[BP] GO:0051172 |
None
|
APP, AURKB, CSNK2A1, DNMT1, DRD2, DRD3, DUSP3, DYRK1A, EGFR, ESR1, ESR2, FABP4, HSPA1A, IGF1R, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TERT, XDH |
2.5625 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.55638 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, FABP3, IGF1R, INSR, MET, PPARA, RORC, SMAD3, SRC, TERT |
2.553 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.53645 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.53645 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, RORC |
2.5217 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.50495 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, EGFR |
2.50495 |
[BP] GO:0030098 |
lymphocyte differentiation
|
AXL, BCL2, FLT3, FUT7, KIT, RORC |
2.49919 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
APP, BCL2, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
2.48457 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.48155 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.48155 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ESR1, HSPA1A, KDR, KIT, MET, MMP1, SMAD3, SRC, TEK |
2.48055 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, MET |
2.46085 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AXL, BCL2, CA2, CA9, CYP1B1, DRD2, EGFR, ESR1, INSR, MET, MMP2, SMAD3, SRC, TEK |
2.44684 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, SRC |
2.43912 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, KDR, SRC |
2.437 |
[BP] GO:0071229 |
cellular response to acid chemical
|
AKR1C3, DNMT1, EGFR, KDR, MMP2, SRC |
2.43628 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.43628 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.43593 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.43593 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, KIT, MET, MMP1, MMP9, SRC, TEK |
2.42474 |
[BP] GO:0060341 |
regulation of cellular localization
|
APP, BCL2, CHRM1, CSNK2A1, DRD1, DRD2, DRD3, EGFR, PTPN1, SMAD3, SRC, TERT |
2.41835 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, DRD2, EGFR |
2.41835 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, APP, BCL2, CHRM1, CSNK2A1, DRD2, DRD3, EGFR, HCAR2, PTPN1, SMAD3, SRC, TERT |
2.41039 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
APP, DRD2, EGFR, KDR, SRC, TEK |
2.40921 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, CYP1B1, ESR1, ESR2, HSPA1A, KIT, PIM1 |
2.40759 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, PPARA, SMAD3, TEK |
2.40759 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, KIT, PTPN1, SRC |
2.3917 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.3917 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.3917 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.3917 |
[BP] GO:0050877 |
None
|
ADORA1, APP, CHRM1, CHRM5, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, INSR, KIT |
2.38211 |
[BP] GO:0051336 |
regulation of hydrolase activity
|
APP, CSNK2A1, DRD2, EGFR, ESR1, F3, HSPA1A, KIT, MMP9, NUAK1, PTPN1, SMAD3, SRC, XDH |
2.37878 |
[BP] GO:0022600 |
None
|
CHRM1, CHRM3, CHRM5, DRD3 |
2.37268 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD11B1, HSD17B1, XDH |
2.37099 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.36943 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD11B1, HSD17B1 |
2.35483 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
FLT3, KDR, KIT, TEK |
2.35112 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.34612 |
[BP] GO:0048169 |
None
|
APP, DRD2, KIT |
2.34612 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, FLT3, INSR, KIT, PTPN1, SRC |
2.3314 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, DRD3 |
2.3308 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.3308 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, TERT |
2.3295 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, BCL2, CHRM1, DRD2, EGFR, HCAR2, SMAD3, SRC |
2.32846 |
[BP] GO:0032989 |
cellular component morphogenesis
|
APP, AXL, BCL2, DRD2, EGFR, MET, SRC, TEK |
2.3278 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.32544 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, APP, AXL, BCL2, CA2, CYP19A1, DRD2, DUSP3, ESR1, HCAR2, HSPA1A, KIT, MMP2, PTPN1, SMAD3, SRC |
2.32495 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.31252 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, CSNK2A1, DRD2, EGFR, FABP3, FABP4, KIT, MET |
2.31059 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.30966 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.30966 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, SMAD3, SRC, TERT |
2.30966 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, PPARA, RORC, SRC |
2.30966 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, BCL2, CSNK2A1, EGFR, HCAR2, HSPA1A, INSR, KDR, MET, PPARA, PTPN1, SMAD3 |
2.30742 |
[BP] GO:0051234 |
None
|
ABCB1, ACHE, ADORA1, AKR1C3, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, CHRM3, CHRM5, DRD1, DRD2, DRD3, EGFR, F10, FABP3, HSPA1A, KIT, MMP9, PPARA, SRC, TERT, XDH |
2.30275 |
[BP] GO:0051179 |
None
|
ABCB1, ACHE, ADORA1, AKR1C3, ALOX5, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, CHRM3, CHRM5, DRD1, DRD2, DRD3, EGFR, ESR1, F10, FABP3, HSPA1A, KIT, MMP9, PPARA, SRC, TERT, XDH |
2.2974 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1 |
2.2974 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, KIT, MMP1, MMP9, SRC, TEK |
2.2974 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTPN1, SRC, TERT |
2.28276 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.276 |
[BP] GO:0051704 |
multi-organism process
|
APP, AXL, BCL2, CHRM2, CYP1A1, DRD3, DYRK1A, EGFR, HSPA1A, INSR, KDR, MET, MMP1, SMAD3, SRC |
2.2738 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, DNMT1, EGFR, IGF1R, INSR, SRC |
2.2738 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.2738 |
[BP] GO:0046541 |
None
|
CHRM1, CHRM3 |
2.2738 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1 |
2.2738 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.2738 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.2738 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.2738 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.2738 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.2738 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.2738 |
[BP] GO:0019725 |
cellular homeostasis
|
APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
2.27244 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AKR1C3, AURKB, BACE1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FABP4, FUT7, HSPA1A, XDH |
2.26848 |
[BP] GO:0035239 |
tube morphogenesis
|
BCL2, EGFR, ESR1, MET, SMAD3, SRC |
2.25531 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, IGF1R, PTPN1, XDH |
2.25531 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, IGF1R, PTPN1, XDH |
2.2454 |
[BP] GO:0007189 |
None
|
DRD1, DRD2, DRD3, DRD5 |
2.2454 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3 |
2.24202 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.23741 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, DRD2, EGFR, INSR, KIT, PTPN1, SRC |
2.21731 |
[BP] GO:0009314 |
response to radiation
|
APP, AURKB, BCL2, DRD1, DRD2, DRD3, EGFR, KIT |
2.21247 |
[BP] GO:0071383 |
None
|
AKR1C3, EGFR, FLT3, SRC |
2.20314 |
[BP] GO:0019098 |
None
|
APP, DRD1, DRD5 |
2.19585 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, DRD3, PPARA |
2.18936 |
[BP] GO:0032412 |
None
|
ABCB1, APP, DRD2, DRD3, GPR35, MMP9 |
2.18905 |
[BP] GO:0032413 |
None
|
DRD2, DRD3, GPR35, MMP9 |
2.18523 |
[BP] GO:0046649 |
lymphocyte activation
|
AXL, BCL2, FLT3, FUT7, KIT, RORC, SMAD3 |
2.17383 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3 |
2.1676 |
[BP] GO:1904035 |
regulation of epithelial cell apoptotic process
|
AKR1C3, KDR, TEK, TERT |
2.1676 |
[BP] GO:0022602 |
ovulation cycle process
|
BCL2, ESR1, KIT, SRC |
2.1676 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.1676 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.16053 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.16053 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.16053 |
[BP] GO:0042060 |
None
|
DRD5, EGFR, PPARA, SMAD3 |
2.14946 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.14946 |
[BP] GO:0090257 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, KIT, SMAD3 |
2.13629 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APP, AURKB, CSNK2A1, DNMT1, DRD3, DUSP3, DYRK1A, EGFR, ESR1, ESR2, FABP4, HSPA1A, IGF1R, KDR, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TERT, XDH |
2.13529 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.13326 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.13326 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.13326 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.13326 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.13326 |
[BP] GO:0016115 |
None
|
AKR1B10, AKR1C3 |
2.13326 |
[BP] GO:0046958 |
None
|
DRD1, DRD5 |
2.13326 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2D6 |
2.13326 |
[BP] GO:0042220 |
None
|
DRD2, DRD3, DRD5 |
2.13326 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.13326 |
[BP] GO:2000352 |
None
|
KDR, TEK, TERT |
2.13326 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.13326 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2 |
2.13326 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.13326 |
[BP] GO:0070201 |
None
|
ACHE, APP, BCL2, CHRM1, DRD2, DRD3, EGFR, HCAR2, PTPN1, SMAD3, SRC |
2.13012 |
[BP] GO:0009410 |
None
|
DRD1, DRD2, DRD3, DRD5, EGFR |
2.1301 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.12291 |
[BP] GO:1901342 |
regulation of vasculature development
|
CYP1B1, F3, KDR, KIT, TEK, TERT, XDH |
2.10888 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR |
2.09679 |
[BP] GO:0098801 |
None
|
ADORA1, DRD2, DRD3 |
2.09679 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, DRD3, DRD5, INSR, PPARA |
2.09473 |
[BP] GO:0035303 |
None
|
ADORA1, CHRM5, DRD2, NUAK1, SMAD3 |
2.09414 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
DRD1, DRD2, DRD3, DRD5, EGFR, KDR |
2.08693 |
[BP] GO:0001763 |
morphogenesis of a branching structure
|
BCL2, DRD2, ESR1, MET, SRC |
2.08282 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.07916 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, CA2, CA7 |
2.06997 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.06997 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
EGFR, ESR1, KIT |
2.06665 |
[BP] GO:1902893 |
None
|
PPARA, SMAD3, TERT |
2.06665 |
[BP] GO:0010907 |
None
|
INSR, PPARA, SRC |
2.06665 |
[BP] GO:0106027 |
None
|
APP, IGF1R, INSR |
2.06665 |
[BP] GO:0006811 |
None
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM5, DRD1, DRD2, DRD3, FABP3, PPARA |
2.05709 |
[BP] GO:0032410 |
None
|
DRD2, DRD3, GPR35, MMP9 |
2.05543 |
[BP] GO:1904063 |
None
|
DRD2, DRD3, GPR35, MMP9 |
2.05543 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
CYP1B1, F3, KDR, TEK, TERT |
2.03914 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, DRD3, DRD5, INSR, PPARA |
2.03877 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.03827 |
[BP] GO:1901989 |
None
|
APP, CDC25B, CYP1A1, TERT |
2.03827 |
[BP] GO:2001240 |
None
|
BCL2, HSPA1A, TERT |
2.03622 |
[BP] GO:0071868 |
None
|
APP, DRD1, DRD5 |
2.03622 |
[BP] GO:1901099 |
None
|
BCL2, HSPA1A, TERT |
2.03622 |
[BP] GO:0071870 |
None
|
APP, DRD1, DRD5 |
2.03622 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
AKR1C3, EGFR, ESR1, FLT3, INSR, KIT, SRC |
2.03622 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3 |
2.03543 |
[BP] GO:0009820 |
alkaloid metabolic process
|
CYP1A2, CYP2D6 |
2.02117 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2D6 |
2.02117 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2D6 |
2.02117 |
[BP] GO:1904180 |
negative regulation of membrane depolarization
|
BCL2, SRC |
2.02117 |
[BP] GO:0010628 |
positive regulation of gene expression
|
APP, DNMT1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, HSPA1A, INSR, KIT, MET, PPARA, RORC, SMAD3, SRC, TERT |
2.01965 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, INSR, KDR, SMAD3, SRC |
2.01434 |
[BP] GO:0042058 |
None
|
ADORA1, APP, EGFR, MMP9 |
2.01361 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
AKR1C3, MMP1, MMP2, MMP9 |
2.01361 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, IGF1R, INSR, KDR, MET, PPARA, RORC, SMAD3, SRC, TERT |
2.00718 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTPN1, SRC |
2.0057 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F10, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, MMP2, PIM1, PTPN1, SMAD3, SRC, TEK, TERT |
7.1402 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, BACE1, CA4, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, F10, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
6.5357 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA1, ADORA3, APP, AXL, BACE1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F10, F3, FLT3, GPR35, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
6.03161 |
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, ADORA1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD5, EGFR, INSR, MET, SRC, TEK |
5.02083 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, BACE1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
4.87537 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX5, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F10, F3, FLT3, FUT7, GPR35, HCAR2, HSD11B1, IGF1R, INSR, KDR, KIT, MET, MMP2, PIM1, PTPN1, SMAD3, SRC, TEK, TERT |
4.43401 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADORA1, ADORA3, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, GPR35, HCAR2, HSD11B1, IGF1R, INSR, KDR, KIT, MET, PTPN1, SRC, TEK |
4.02655 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, CHRM3, EGFR, TEK |
3.38734 |
[CC] GO:0031253 |
None
|
ADORA1, CA4, CA9, DRD1, DRD2, DRD5, INSR, SRC |
2.9171 |
[CC] GO:0009986 |
cell surface
|
ABCB1, ACHE, APP, AXL, BACE1, CA4, EGFR, F3, MET, TEK |
2.80477 |
[CC] GO:0098793 |
None
|
ADORA1, APP, CHRM1, CHRM2, CHRM3, DRD2 |
2.74063 |
[CC] GO:0045202 |
None
|
ACHE, APP, CHRM1, CHRM2, CHRM3, CHRM5, EGFR |
2.62423 |
[CC] GO:0043679 |
None
|
CHRM1, CHRM2, CHRM3, DRD2 |
2.60895 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.59519 |
[CC] GO:0031224 |
None
|
ABCB1, ACHE, ADORA1, ADORA3, ALPL, APP, AXL, BACE1, CA12, CA14, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F10, F3, FLT3, FUT7, GPR35, HCAR2, HSD11B1, IGF1R, INSR, KDR, KIT, MET, TEK |
2.48045 |
[CC] GO:0045121 |
membrane raft
|
APP, BACE1, EGFR, INSR, KDR, SRC, TEK |
2.35765 |
[CC] GO:0098857 |
membrane microdomain
|
APP, BACE1, EGFR, INSR, KDR, SRC, TEK |
2.34364 |
[CC] GO:0044463 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, CHRM1, CHRM2, CHRM3, DRD1, DRD2, DRD5, INSR, SRC |
2.31963 |
[CC] GO:0120038 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, CHRM1, CHRM2, CHRM3, DRD1, DRD2, DRD5, INSR, SRC |
2.31963 |
[CC] GO:0044306 |
None
|
CHRM1, CHRM2, CHRM3, DRD2 |
2.276 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.13326 |
[CC] GO:0097730 |
None
|
DRD1, DRD2, DRD5 |
2.09679 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BACE1, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, EGFR, F10, FLT3, HSD11B1, PTPN1 |
2.08987 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, DRD1, DRD2, DRD3, DRD5, DYRK1A, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
10.9618 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, DUSP3, DYRK1A, EGFR, F10, F3, FLT3, FUT7, HSD11B1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK, TERT, XDH |
10.9598 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PPARA, SRC, TEK |
10.7843 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, ESR1, ESR2, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, XDH |
10.4275 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.2936 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, PPARA, RORC, TEK |
9.09095 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
9.00932 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
8.19008 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, PPARA, RORC, TEK |
8.14116 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, PPARA, RORC, SMAD3, TEK |
8.01446 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, PPARA, RORC, TEK |
7.88821 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
7.61639 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, TEK |
6.95926 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, TEK |
6.95926 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.65391 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.53934 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, DRD1, DRD2, DRD3, DRD5, ESR1, ESR2, F10, KIT, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, TERT, XDH |
5.97401 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 |
5.90154 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.69298 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
5.66059 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.47592 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR, KIT |
5.43343 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, DNMT1, ESR1, ESR2, MMP1, MMP2, MMP9, PPARA, PTPN1, RORC, SMAD3 |
5.30626 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.24688 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.94603 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.81452 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
4.76988 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, CHRM3, DRD1, DRD2, DRD3, DRD5 |
4.47214 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
4.3393 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.27438 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TERT |
4.18656 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
4.17984 |
[MF] GO:0042562 |
hormone binding
|
ACHE, CHRM3, EGFR, HSD17B1, IGF1R, INSR |
4.14845 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.10431 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
3.88859 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, BACE1, CDC25B, CSNK2A1, DUSP3, DYRK1A, EGFR, F10, F3, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK |
3.77336 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, XDH |
3.74458 |
[MF] GO:0008227 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD2 |
3.73275 |
[MF] GO:0004629 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5 |
3.47543 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.40908 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, ESR1, ESR2, F10, KIT, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, TERT, XDH |
3.28055 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, SRC |
3.26397 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, HSD11B1, HSD17B1, XDH |
3.13528 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.11991 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ADORA1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, XDH |
3.11749 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, SRC |
3.10978 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC |
3.08835 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD11B1, HSD17B1, XDH |
3.07271 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
3.06991 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
3.06991 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, BCL2, CSNK2A1, DRD2, DYRK1A, EGFR, ESR1, ESR2, FLT3, IGF1R, KDR, KIT, MET, MMP9, SMAD3, TERT, XDH |
2.96676 |
[MF] GO:0005524 |
ATP binding
|
ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.94539 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, XDH |
2.91141 |
[MF] GO:0043168 |
anion binding
|
ABCB1, APP, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.87669 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.87669 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.83669 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.80712 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, FLT3, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SMAD3, SRC |
2.77678 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, MET, PPARA, PTPN1, SMAD3 |
2.7637 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, PPARA, RORC |
2.7637 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, PPARA, RORC |
2.7637 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.67841 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.6276 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.62667 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.59519 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ABCB1, ADORA1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, DRD1, DRD2, DRD3, DRD5, DYRK1A, EGFR, ESR1, ESR2, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH |
2.55679 |
[MF] GO:0042578 |
None
|
ADORA1, ALPL, CDC25B, CHRM1, CHRM3, CHRM5, DUSP3, PTPN1 |
2.55286 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, PPARA, RORC |
2.50495 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, GPR35, HCAR2 |
2.46085 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, HSD11B1, HSD17B1 |
2.4453 |
[MF] GO:0001588 |
None
|
DRD1, DRD5 |
2.43628 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.43628 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.43628 |
[MF] GO:0019899 |
enzyme binding
|
APP, AURKB, BACE1, BCL2, CDC25B, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, ESR2, F3, HSPA1A, KIT, MET, PPARA, PTPN1, SMAD3, SRC, TEK |
2.42884 |
[MF] GO:0005057 |
signal transducer activity, downstream of receptor
|
EGFR, INSR, KDR, KIT, SMAD3 |
2.40868 |
[MF] GO:0016788 |
None
|
ACHE, ADORA1, ALPL, CA1, CA2, CDC25B, CHRM1, CHRM3, CHRM5, DUSP3, PTPN1 |
2.3917 |
[MF] GO:0004033 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.30966 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.30966 |
[MF] GO:0004435 |
None
|
CHRM1, CHRM3, CHRM5 |
2.2738 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1C3, HSD11B1, HSD17B1 |
2.2738 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.2738 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.2738 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
AKR1C3, HSD11B1, HSD17B1 |
2.19585 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.19585 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, F10, F3, FABP3, FABP4, HSD17B1, PPARA, RORC |
2.1676 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.13326 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.13326 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ABCB1, ADORA1, APP, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.07986 |
[MF] GO:0035639 |
purine ribonucleoside triphosphate binding
|
ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.06665 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2D6 |
2.03622 |
[MF] GO:0005021 |
vascular endothelial growth factor-activated receptor activity
|
FLT3, KDR |
2.02117 |
[MF] GO:0001758 |
None
|
AKR1B10, AKR1C3 |
2.02117 |
[MF] GO:0030235 |
nitric-oxide synthase regulator activity
|
EGFR, ESR1 |
2.02117 |
[MF] GO:0004032 |
None
|
AKR1B1, AKR1C3 |
2.02117 |
[MF] GO:0001609 |
None
|
ADORA1, ADORA3 |
2.02117 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, HSD17B1, RORC |
2.01361 |